CEOInterviews.AI
Start App
Get an email when George Church gives a new interview
One email per new interview. Unsubscribe in one click.
George Church
Professor of Genetics, Wyss Institute at Harvard University

DISRUPTIVE: SYNTHETIC BIOLOGY Pamela Silver & George Church

📅 Jan 16, 2026 Terrence McNally 57 MIN 24 VIEWS 122 SEGMENTS · 3 SPEAKERS
I’m excited to offer the first episode of DISRUPTIVE, my new monthly podcast series produced with Harvard’s Wyss Institute for Biologically Inspired Engineering. The mission of the Wyss Institute is to: Transform healthcare, industry, and the environment by emulating the way nature builds, with a focus on technology development and its translation into products and therapies that will have an impact on the world in which we live. Their work is disruptive not only in terms of science but also in how they stretch the usual boundaries of academia. In this inaugural episode, Wyss core faculty mem...

Questions asked in this interview

12
  1. 1:47And what do we need to do now to move in that direction?
  2. 6:44What year is it that we believe this?
  3. 17:01How is that going to help us with this threat that we face?
  4. 24:51Could you speak a bit about that?
  5. 29:06And is that something that is only up to one, or is that part of a partnership and a collaborative sort of nature of responsibility?
  6. 32:59And what did that visit, that vision inspire in you?
  7. 34:53People confuse what's impossible today with what's impossible tomorrow. Could you talk about that?
  8. 37:50You reprogram natural organisms to do things they wouldn't normally do. How do you do that?
  9. 40:42What you found that worked and then how it worked?
  10. 45:41Some will say that society as a whole has gotten pretty bad at assessing risk and you can cite the Wall Street subprime derivatives crash, the war in Iraq, both were seemingly based on best case scenarios. How do you assess risk?
  11. 47:54What are some of the other ways that safety as an initial question influences what you're doing?
  12. 54:01Is that basically where you stand?
Terrence McNally 0:05 ↗
Hello, I'm Terrence McNally, and you're listening to Disruptive, the podcast from Harvard's Wyss Institute of Biologically Inspired Engineering. The mission of the Wyss Institute is to transform healthcare, industry, and the environment by emulating the way nature builds, with a focus on technology development and its translation into products and therapies that will have an impact on the world in which we live. The Wyss is not interested in making incremental improvements to existing materials and devices, but in shifting paradigms.
Today's episode of Disruptive: Synthetic Biology. "We have within our grasp the technology to change evolution. This could change the course of biological life." Those are the words of Paul Berg, Nobel Laureate and a pioneer of genetic engineering. What sorts of breakthroughs are possible by modifying an organism's genome? Something we're now able to do ever more cheaply and efficiently. The basic idea behind synthetic biology, according to one of today's guests, George Church, is that natural organisms can be reprogrammed to do things they wouldn't normally do, things that might be useful to people. Researchers have learned not only how to read an organism's genetic code, but also how to write and insert new code into that organism. Did you know that we're already able to program microbes to treat wastewater, generate electricity, manufacture jet fuel, create hemoglobin, and fabricate new drugs? What sounds like science fiction to most of us might be a reality within our lifetimes: the ability to build diagnostic tools that live within our bodies, or treatments to eradicate malaria from mosquito lines, or possibly even to make genetic improvements in humans that are passed down to future generations. These can be game-changers.
In pursuit of these high-impact benefits, what sort of risks are we looking at? Will there be unintended consequences to humankind or to our ecosystem? When will we know the effects as they play out over generations? This conversation about the promise and the risks of synthetic biology has come to a head recently with the publication of two public letters. The first, signed by a small group of prominent researchers, posted on March 13th in the journal Nature. The second, signed by 18 leaders in the field, most of whom had gathered in Napa, California to come up with a path forward, posted March 19th to the journal Science. The Napa group wrote of unparalleled potential for modifying human and non-human genomes to cure genetic diseases in humans and to reshape the biosphere for the environment and human societies, and they warned of unknown risks to human health and well-being. Bottom line: how do we make this work so that humanity enjoys the benefits of the breakthroughs without suffering unintended negative consequences? And what do we need to do now to move in that direction? We'll explore these questions with Pam Silver and George Church, one of the signers of the Napa Group letter.
Among the many positions and titles they hold, both are founding members of the Wyss Institute. Pamela Silver, professor of systems biology at Harvard Medical School, received her BS in chemistry and PhD in biochemistry from the University of California and did postdoctoral work at Harvard. Pamela is building cell-based machines, designing novel therapeutics, and re-engineering photosynthetic bacteria to produce hydrogen and other fuels. She's won many awards and grants, and serves on a number of private and public advisory boards. Most recently, she was recognized with a large award from the Department of Energy to develop electrofuels. Welcome, Pam Silver, to Disruptive.
Pamela Silver 3:36 ↗
Hi, Terry. How are you?
Terrence McNally 3:38 ↗
I'm good. I'm good. You know, I'd like listeners to get a feel for the people behind the work and the ideas that we talk about. Pam, so can you take us back and tell us a bit about your path to the work that you do today? And feel free to mention mentors, turning points, moments of decision.
Pamela Silver 3:55 ↗
Sure. I love to talk about myself, and this could take the whole hour, by the way. Let me begin by saying that I actually grew up in California in the Silicon Valley area during the birth of the personal computer, and my family was intimately involved in that. My best friend's father ran one of the biggest computer companies.
So science and engineering were heavily encouraged in that environment. I actually had precocious math ability as a girl, which was considered unusual at the time. I think I actually became the subject of someone's PhD thesis at Stanford because of this. And I won the IBM math contest, and the prize was a slide rule, if anybody knows what that is anymore.
Terrence McNally 4:44 ↗
Actually, Pam, I love the fact that I used to sort of feel intimidated by the folks who had slide rules in high school. And when I realized that they had become obsolete, it was like a sense of personal triumph.
Pamela Silver 4:58 ↗
Well, they became obsolete in part because of my best friend's father, who was one of the inventors of the first calculator. And I remember once being at their house doing our PCM homework, and he came home and threw down the first programmable calculator and said, "Here, girls, try this."
Wow. So the environment was right for me in terms of innovation and being in the right place at the right time. I first started in math, migrated to physics, and realized at the time in physics that the choices were either to work on chaos theory or work on high-energy physics. And the trouble with high energy was that you would have to work at an accelerator, and you only got to do an experiment once a year if you were lucky. And then if the pen broke on the readout, you were screwed. So that was out because I really wanted to do experiments. And so I ended up migrating to chemistry. And then I think a key event for me was being sort of at the right place at the right time during the molecular biology revolution, which was just absolutely transformative. And I think looking back and looking at the history of synthetic biology, it is of course the precursor of that is molecular biology, where we learned how to engineer single genes at a time. And molecular biology was very important in telling us that biology was fundamentally modular, and that is one of the underpinnings of synthetic biology. What do I mean by that? So the gene was the original modular unit of biology. You could transfer a trait with a gene from one organism to another.
Terrence McNally 6:44 ↗
What year is it that we believe this?
Pamela Silver 6:46 ↗
Oh, well, this was the work of Mendel. You know, this goes back early 1900s.
Terrence McNally 6:50 ↗
And it holds until?
Pamela Silver 6:53 ↗
Well, then once people like you mentioned Paul Berg and others were able to start cutting and pasting DNA of organisms, in particular bacteria at the time, it became evident that there was modularity that extended beyond the gene. So we could take parts of genes and move them to other genes, and they would function. So there's something called a promoter. You can move that promoter around, and it will regulate different genes. So that's the definition of modularity: being able to take something out of its natural context and move it somewhere else and have it function in the way it's supposed to. Let me preface that by saying that this goes back to what I consider the so-called founding of synthetic biology, which I was involved in here in Boston in about 2002. I got together with a group of computer scientists and bioengineers at MIT when we called ourselves the synthetic biology working group, and I was the token biologist. And the premise that they had was that biology should be as easy to engineer as it is to build a computer chip, and why isn't it? So that was the underlying premise. And then what led to this idea of employing modularity of biology is much the same as what an engineer does or an electrical engineer, where they build a circuit and they use different parts to build that circuit on the chip, and they know the characteristics of those parts so they can predict how the chip will behave. This is how the computer industry works.
Why is biology the best engineering material? Life can do a lot of things, and it can do it better than what engineers can often do, or it can do it in ways that are more compatible, say, with interface with ourselves or with the rest of nature. So one of those is this exquisite sensitivity of biology. I'll use as an example the olfaction system, your ability to smell. Your olfactory system can sense a single molecule. There's very little that can do that in real engineering. We already discussed the ability to use modules. Much like electrical systems, biology is capable of sending and receiving signals. Of course, in the nervous system, this is standard. But there's also cell communication that occurs in all parts of your body, in all parts of nature, between different bacteria in your gut. They're talking to each other. What's that conversation about? We need to understand that. And once we can understand that, we can use it to engineer, for example, your gut. This is a project we're working on where we want to reboot your gut bacteria. And then lastly, of course, biology, unlike machines, can duplicate itself. Now, as synthetic biologists, part of our responsibility is to make sure that duplication is accurate, doesn't cause mutation or things to go haywire. This is part of our responsibility to make sure that when we build these systems, they don't go wild, they don't go out of control, and they don't integrate into the natural world.
Terrence McNally 10:24 ↗
Yeah. In other words, the phenomenal opportunities that we face here, once we are able to tap into biology to work with us and for us, lays with it that responsibility.
Pamela Silver 10:36 ↗
Yes. But keep in mind that we have already been employing biology in our service for ages. For example, we engineer plants through evolution. We evolve them to have certain phenotypes or certain characteristics. We as humans have been evolving plants to do what we want: grow with certain fertilizers, grow in more drought-like conditions, grow in more crowded conditions, have better yield, be insect tolerant. So we've been doing this, and if you look at the original corn that Indians had, the corn we eat today looks completely different. So as humans, we've already been mucking around with nature. So I think it's important to keep that in mind. That was using evolution, but using it for our benefit. Now we're just better at it.
Terrence McNally 11:34 ↗
Right? We know more, and we have much more powerful computational tools to work with.
Pamela Silver 11:40 ↗
It is that about 50 years of molecular biology, which culminated in the sequencing of the human genome, and now what we really call citizen science, where essentially anyone can sequence anything. It's cheap enough to do DNA sequencing now of genomes; it's one of the cheapest commodities you have in science, and can be done on a benchtop. So now that we have all this information close at hand, we can employ that to start engineering organisms, and that was brought to us by this essentially 50 years of molecular biology.
And so it's a wonderful deep history. Many of us were heavily engaged in that. And now to be able to see the fruit of that, to think about this idea that we can use biology in a predictable, cheaper, and faster way to engineer it to do good is really the definition of synthetic biology. As you pointed out at the beginning, it is not about whether we could make whole new organisms. That's an approach to synthetic biology. The goals really are this faster, cheaper, more predictable engineering of biology for good.
Terrence McNally 12:57 ↗
On your website, you say, "We seek to implement design strategies used by nature as well as to go where evolution may not readily go." Now, that's something which might make someone nervous. Could you say what you mean by that, because I think it's pretty interesting.
Pamela Silver 13:10 ↗
So evolution, if you believe the standard theory, would be selection of the organisms that can thrive in a certain environment, right? And they do that simply: the others die, and the good ones grow. So what you can do is apply artificial evolution. So I could say, for example, I want to make a plant that can grow without hardly any water. So I set up an experimental condition in the laboratory, and then I put lots of plants out there, and I look for the guys that can grow. So that's imitating a condition and allowing evolution to occur in the laboratory. You can also accelerate it in different ways by using the tools of molecular biology to help accelerate evolution, but that might not be a case where you would be able to find that drought-resistant plant out in nature.
Terrence McNally 14:09 ↗
So that's where you take a path nature is on already. You find things you've learned to actually accelerate the pace of evolution in a direction that you choose.
Pamela Silver 14:17 ↗
Not only that, but you also can apply. So I used a real-world example that might resonate for people, but you could also pick other unusual conditions, like an unusual drug or something like that, that you really want organisms to be able to grow in the presence of where they normally don't. So you can apply in sort of an artificial evolutionary condition as well that might not be seen out in the real world, or you might anticipate, say, you want to send things to Mars, right? So you might anticipate, okay, here's what it's like on Mars. Can I evolve some organisms here on Earth that might live on Mars?
Terrence McNally 14:59 ↗
Now that we've defined some terms and laid out some history, can you talk a bit about what you're working on these days?
Pamela Silver 15:05 ↗
Well, I can talk about the two that are the most exciting to my laboratory right now.
Terrence McNally 15:09 ↗
Absolutely.
Pamela Silver 15:10 ↗
So the one I just mentioned was engineering the gut so that it can respond and possibly act as a therapeutic. So both a diagnostic and a therapeutic. So imagine first of all the real-world problem, and I will take it to the human level for a moment. So here's a real-world problem: if you have a chronic disease of the gut, so you're living, you're not going to die from it, but it's a chronic disease. You are in pain all the time, for example, with Crohn's or inflammatory bowel disease. What if you had a bacteria that was native to the gut but had been engineered so that when you have inflammation, it can sense that inflammation and then secrete or let something out of it that will treat that inflammation? So it's like a sentinel. It's standing there in your gut, ready on alert for when something bad happens.
And we can do this now. Actually, this will be fairly short-term. Another one, a huge cost to the military and to the world in general, is travelers' diarrhea. In point of fact, when troops are deployed overseas, they're down for 3 to 5 days. And the cost to us, the taxpayers, is huge. Many people do not realize this. So imagine if you could create a therapeutic gut bacteria that would prevent travelers' diarrhea. So that's ongoing. That is research that is ongoing in our laboratory by trying to create artificial communities of bacteria that you could regulate on demand.
Terrence McNally 16:55 ↗
How far away is that if DARPA has its way?
Pamela Silver 16:57 ↗
Two and a half years.
Terrence McNally 17:01 ↗
The evolution of antibiotic-resistant microbes through the overuse and abuse of antibiotics could lead to the end of the antibiotics era that we take for granted. And I suffered a staph infection, a pretty severe staph infection, a couple of years ago. I take that threat seriously. You've engineered this natural gut bacteria we spoke about that can remember exposure to antibiotics in mice. How is that going to help us with this threat that we face?
Pamela Silver 17:26 ↗
Well, first of all, that system is highly modular. So I can make it respond not just to antibiotics, but to inflammation, to other drugs. So it's the perfect example of a synthetic circuit that's highly modular. So it's very useful. What it could do is help reduce the amount of antibiotics that's being used, because it can not only register whether you've been exposed to antibiotics or not, but how much. And it can also act as a counter and say for how long you've been exposed to those antibiotics. So in that way, it's acting as a probe, as a diagnostic.
Terrence McNally 18:05 ↗
Mhm.
Pamela Silver 18:05 ↗
But let me give you another potential real-world application that could happen now. So as you know, there's a big issue around use of antibiotics in the livestock industry, and perhaps this is impacting on our own health and our own resistance. So in the poultry industry, don't laugh, there's a lot of inflammation that's a problem, and oftentimes they sample only a few chickens in the flock. So if you could use our bacteria in a contained environment to diagnose those chickens, you would know what's going on in the whole flock. And so that's a relatively cheap, fast way to engineer the poultry population without having to directly engineer every chicken.
Terrence McNally 18:55 ↗
Right. And if I'm following you right now, they just blanketly use a lot of antibiotics for the fear that some of them might have problems. Right. And what you're saying is, using it as a diagnostic, you could selectively say we don't need to give it to everyone.
Pamela Silver 19:08 ↗
Right. Right.
Terrence McNally 19:10 ↗
You've set some very important goals for synthetic biology. One is to get beyond the dependency on petroleum, and the other is to design a sustainable Earth. And I like both of those.
Pamela Silver 19:19 ↗
Yes.
Terrence McNally 19:20 ↗
And they're big and they're enormously positive. How are you working toward those two goals right now in the lab?
Pamela Silver 19:26 ↗
Let me tell you about the bionic leaf.
Terrence McNally 19:28 ↗
Yes, I love the bionic leaf.
Pamela Silver 19:31 ↗
The thing I am most excited about today. And let me preface this story by saying this is a case of a wonderful collaborative effort. I met Dan Nocera, who used to be at MIT and is now here at Harvard in the chemistry department. I literally met him at a cocktail party, and he had just moved to Harvard, and he said, "I've been wanting to meet you," because he had developed something called the artificial leaf. He's an inorganic chemist. He has developed a catalyst essentially that will act like a leaf. It will do what's called the water-splitting reaction, and it will do it cheaply. So the water-splitting reaction generates hydrogen and oxygen. That's the front end. So you've got a solar panel hooked up to his magic artificial leaf. What do you do with that? So it's the age-old problem of how do you store solar energy? Now, Dan's original concept of this, and I was interested in this as well, is a hydrogen-based economy. Now that comes and goes in terms of popularity. Hydrogen, by the way, is a clean-burning fuel, so it has that advantage. But he was sort of stuck with, okay, now I've got something that makes hydrogen. What do I do with it? Okay, so there's some hydrogen-based cars, but at the time DOE was pushing the electrical car, so what are you going to do with this thing? So we said, well, look, there are bacteria that can live on hydrogen. They eat hydrogen. All they need is CO2 and hydrogen. And so we then interfaced these bacteria together with the artificial leaf so that the bacteria live in the presence of the artificial leaf and they make stuff, in this case a pseudo-fuel. So this is a way of taking sunlight and converting it into biological carbon. It's a drop-in, that means you can just essentially put it in water. It could be used in the developing world, it can be scaled up, and we also call it the bionic leaf because it's the interface between the inorganic and the living system that has been engineered.
Terrence McNally 21:46 ↗
And one of the things that you point out about this is that just in the same way that nature has decentralized local energy, once we deploy this technology, we can also look toward local decentralized energy rather than depending on massive powerful companies with grids.
Pamela Silver 22:03 ↗
When I was working on this early on several years ago, I owned the domain name personalized energy because that's how I wanted to think about it, that way that you would, for example, grow a bunch of bacteria on your roof and they would make stuff for you. So that's how Dan and I think about it, is this idea that, and in a way people who have solar panels are already doing this. They're already decentralizing even though in some cases they're selling it back to the grid. But imagine if you could use that to drive production in your own home of either energy or make your own commodities. You need a certain drug. What if you had the bacteria programmed to make a drug? I mean, this is getting, you know, way out there in the future, but this gives you the front end to do that.
Terrence McNally 22:54 ↗
Photosynthesis is, none of us would be here without it. When I've looked into all this, that photosynthesis is the only free lunch there is. Sunlight comes and photosynthesis, you know, converts it, and suddenly we have things happening. When you begin to tap into that power and that ability, that is really enormous.
Pamela Silver 23:16 ↗
Well, this is why I've called the engineering of the photosynthetic machinery. I think it should be a grand challenge because right now, as you know, plants are the least efficient at harvesting sunlight. It's about 1% or so. Photosynthetic bacteria get a little better, and algae, I think, hit the peak at 5%. Actually, there may be some bacteria that can get up to 8%. Our leaf as of right now is doing about 5%, which makes it equivalent to algae, which is huge. I know it doesn't sound like a lot, but we're doing better than a real leaf, and we're doing almost as good as the best thing on Earth.
Terrence McNally 23:59 ↗
Right. Well, Dan, I have a quote from Dan here, and I've seen him make a presentation on this, which is one thing that got me interested in all of this. He says, "There's been 2.66 billion years of evolution, and Pam and I working together a year and a half have already achieved the efficiency of photosynthesis."
Pamela Silver 24:13 ↗
Thanks, Dan. Well, evolution is an interesting question in and of itself, which I don't want to get too close to because many people have different opinions on it. But going back to your thing about evolving organisms synthetically, there's another way to think about this problem. So we have engineered something that is potentially scalable and more efficient and has the potential to be better. But what if we go back to life and say, can we now make living photosynthesis better? And I still think that should be a grand challenge.
Terrence McNally 24:51 ↗
Are there unique challenges to the field of synthetic biology? You've made the point a few times to do things for good so that things don't get loose in the wild and so on. I would think predictive, ethical, political, cultural, some of the challenges that synthetic biology faces. Could you speak a bit about that?
Pamela Silver 25:08 ↗
A little bit, to be honest. So I've been very impressed with the community in that it has caught the fascination of not just engineers and scientists, but also ethicists and policy people. And so the community has sort of grown together, and we have a lot of people thinking about ethics and policy. I think MIT may even almost have a department of it. And that's a great thing because I'm not a policy person, although I just got back from the White House, and I'm learning more about it, but I'm a scientist, and I like the idea that there's this community that I can go talk to and learn more about what these issues are and what real people think about. So I think that's one way that some of these challenges are being addressed. It's also being addressed by the press quite a bit, which is a good thing, and sometimes a bad thing, but again the discussion is quite open, and I think it's caught the fascination, certainly caught the fascination of young people. I have more students that want to work in my laboratory than I had when I worked on cancer, and this has just caught the imagination probably much in the way that the IT industry catches the imagination of young people. I think synthetic biology has also caught their imagination, and we should not lose that over issues of policy or issues of fear. We should somehow understand how to nurture that.
Terrence McNally 26:43 ↗
Let's talk a bit about the fear. You've been working in this arena for quite a while. When you're looking at experiments and research, how do you deal with the possibility that something could go wrong?
Pamela Silver 26:53 ↗
Well, for most of my scientific career, I worked on laboratory organisms that are contained and are not pathogens, and the recombinant DNA aspect had already been dealt with with the Asilomar meeting in the early days, and there was a moratorium in Cambridge.
Terrence McNally 27:14 ↗
Asilomar was back in '75.
Pamela Silver 27:16 ↗
Yeah, that was the mid-'70s. And to be clear, that was the product of scientists talking about the dangers of release. They did not talk about malicious behavior. They did not talk about biowarfare. They simply addressed the issues of release.
Terrence McNally 27:36 ↗
So if I can say, involving no bad actors, it's just even doing our best, could something go wrong?
Pamela Silver 27:42 ↗
Right. What came out of Asilomar were the biosafety rules which we still live by. So we have carefully controlled facilities. If I want to, I've worked on HIV. There's a biosafety containment lab here at Harvard where we can work on HIV. So this is the mechanism that we've lived with, and it's worked. The data is there. It's worked. However, now that we are starting to do things... So you asked about me. Me personally, yeah, I bought into in general recombinant DNA is safe based on the many years of experience and the biosafety rules. However, moving forward as we start to explore this, the ability to sequence anything is powerful, and the ability to potentially manipulate anything is powerful. So as we move forward, we start to get into the realm of organisms that we don't normally handle, and we don't even know if they can be pathogenic or not. So for example, if we're working with the gut microbiome, there may be organisms in someone's gut that could be bad for someone else.
Terrence McNally 28:54 ↗
Right.
Pamela Silver 28:55 ↗
Sure. And so this is where I pay attention to my students and that they are actually following the rules for containment. It's not a game.
Terrence McNally 29:06 ↗
How would you define responsible conduct? And is that something that is only up to one, or is that part of a partnership and a collaborative sort of nature of responsibility?
Pamela Silver 29:16 ↗
Well, so I think it's like everything. First of all, there's personal responsibility. You have a personal responsibility to protect yourself and to protect your neighbors in this case in the laboratory, and to be open about what you're doing. So I think there's a need for openness about the research you're doing, not just to your neighbors but to all the people around you, and we should have more open sharing of what people are doing. Then there's this issue of citizen science, where people...
are going to start experimenting on themselves and or obtaining their own genomes and thinking about that. And so I think that's where we need, and I hate to sound I hate to sound trivial, but we really just need more science education.

55 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Church, G. (2026, January 16). DISRUPTIVE: SYNTHETIC BIOLOGY Pamela Silver & George Church [Interview transcript]. Terrence McNally. CEOInterviews.AI. https://ceointerviews.ai/interview/3276871/

MLA

George Church. "DISRUPTIVE: SYNTHETIC BIOLOGY Pamela Silver & George Church." Terrence McNally, 16 Jan. 2026. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3276871/.

BibTeX
@misc{church2026_3276871,
  author       = {George Church},
  title        = {DISRUPTIVE: SYNTHETIC BIOLOGY   Pamela Silver \& George Church},
  howpublished = {Interview transcript, Terrence McNally. CEOInterviews.AI},
  year         = {2026},
  month        = {jan},
  url          = {https://ceointerviews.ai/interview/3276871/},
  note         = {Speaker-attributed transcript with timestamps}
}